Cargando…

Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells

INTRODUCTION: Advanced glycation end products (AGEs) have been introduced to be involved in the pathogenesis of osteoarthritis (OA). The influence of AGEs on osteoarthritic fibroblast-like synovial cells (FLS) has been incompletely understood as yet. The present study investigates a potential influe...

Descripción completa

Detalles Bibliográficos
Autores principales: Franke, Sybille, Sommer, Manfred, Rüster, Christiane, Bondeva, Tzvetanka, Marticke, Julia, Hofmann, Gunther, Hein, Gert, Wolf, Gunter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787298/
https://www.ncbi.nlm.nih.gov/pubmed/19735566
http://dx.doi.org/10.1186/ar2807
_version_ 1782174903007444992
author Franke, Sybille
Sommer, Manfred
Rüster, Christiane
Bondeva, Tzvetanka
Marticke, Julia
Hofmann, Gunther
Hein, Gert
Wolf, Gunter
author_facet Franke, Sybille
Sommer, Manfred
Rüster, Christiane
Bondeva, Tzvetanka
Marticke, Julia
Hofmann, Gunther
Hein, Gert
Wolf, Gunter
author_sort Franke, Sybille
collection PubMed
description INTRODUCTION: Advanced glycation end products (AGEs) have been introduced to be involved in the pathogenesis of osteoarthritis (OA). The influence of AGEs on osteoarthritic fibroblast-like synovial cells (FLS) has been incompletely understood as yet. The present study investigates a potential influence of AGE-modified bovine serum albumin (AGE-BSA) on cell growth, and on the expression of proinflammatory and osteoclastogenic markers in cultured FLS. METHODS: FLS were established from OA joints and stimulated with AGE-BSA. The mRNA expression of p27(Kip1), RAGE (receptor for AGEs), nuclear factor kappa B subunit p65 (NFκB p65), tumor necrosis factor alpha (TNF-α, interleukin-6 (IL-6), receptor activator of NFκB ligand (RANKL) and osteoprotegerin was measured by real-time PCR. The respective protein expression was evaluated by western blot analysis or ELISA. NFκB activation was investigated by luciferase assay and electrophoretic mobility shift assay (EMSA). Cell cycle analysis, cell proliferation and markers of necrosis and early apoptosis were assessed. The specificity of the response was tested in the presence of an anti-RAGE antibody. RESULTS: AGE-BSA was actively taken up into the cells as determined by immunohistochemistry and western blots. AGE-induced p27(Kip1 )mRNA and protein expression was associated with cell cycle arrest and an increase in necrotic, but not apoptotic cells. NFκB activation was confirmed by EMSAs including supershift experiments. Anti-RAGE antibodies attenuated all AGE-BSA induced responses. The increased expression of RAGE, IL-6 and TNF-α together with NFκB activation indicates AGE-mediated inflammation. The decreased expression of RANKL and osteoprotegerin may reflect a diminished osteoclastogenic potential. CONCLUSIONS: The present study demonstrates that AGEs modulate growth and expression of genes involved in the pathophysiological process of OA. This may lead to functional and structural impairment of the joints.
format Text
id pubmed-2787298
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27872982009-12-02 Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells Franke, Sybille Sommer, Manfred Rüster, Christiane Bondeva, Tzvetanka Marticke, Julia Hofmann, Gunther Hein, Gert Wolf, Gunter Arthritis Res Ther Research article INTRODUCTION: Advanced glycation end products (AGEs) have been introduced to be involved in the pathogenesis of osteoarthritis (OA). The influence of AGEs on osteoarthritic fibroblast-like synovial cells (FLS) has been incompletely understood as yet. The present study investigates a potential influence of AGE-modified bovine serum albumin (AGE-BSA) on cell growth, and on the expression of proinflammatory and osteoclastogenic markers in cultured FLS. METHODS: FLS were established from OA joints and stimulated with AGE-BSA. The mRNA expression of p27(Kip1), RAGE (receptor for AGEs), nuclear factor kappa B subunit p65 (NFκB p65), tumor necrosis factor alpha (TNF-α, interleukin-6 (IL-6), receptor activator of NFκB ligand (RANKL) and osteoprotegerin was measured by real-time PCR. The respective protein expression was evaluated by western blot analysis or ELISA. NFκB activation was investigated by luciferase assay and electrophoretic mobility shift assay (EMSA). Cell cycle analysis, cell proliferation and markers of necrosis and early apoptosis were assessed. The specificity of the response was tested in the presence of an anti-RAGE antibody. RESULTS: AGE-BSA was actively taken up into the cells as determined by immunohistochemistry and western blots. AGE-induced p27(Kip1 )mRNA and protein expression was associated with cell cycle arrest and an increase in necrotic, but not apoptotic cells. NFκB activation was confirmed by EMSAs including supershift experiments. Anti-RAGE antibodies attenuated all AGE-BSA induced responses. The increased expression of RAGE, IL-6 and TNF-α together with NFκB activation indicates AGE-mediated inflammation. The decreased expression of RANKL and osteoprotegerin may reflect a diminished osteoclastogenic potential. CONCLUSIONS: The present study demonstrates that AGEs modulate growth and expression of genes involved in the pathophysiological process of OA. This may lead to functional and structural impairment of the joints. BioMed Central 2009 2009-09-07 /pmc/articles/PMC2787298/ /pubmed/19735566 http://dx.doi.org/10.1186/ar2807 Text en Copyright ©2009 Franke et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Franke, Sybille
Sommer, Manfred
Rüster, Christiane
Bondeva, Tzvetanka
Marticke, Julia
Hofmann, Gunther
Hein, Gert
Wolf, Gunter
Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells
title Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells
title_full Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells
title_fullStr Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells
title_full_unstemmed Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells
title_short Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells
title_sort advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787298/
https://www.ncbi.nlm.nih.gov/pubmed/19735566
http://dx.doi.org/10.1186/ar2807
work_keys_str_mv AT frankesybille advancedglycationendproductsinducecellcyclearrestandproinflammatorychangesinosteoarthriticfibroblastlikesynovialcells
AT sommermanfred advancedglycationendproductsinducecellcyclearrestandproinflammatorychangesinosteoarthriticfibroblastlikesynovialcells
AT rusterchristiane advancedglycationendproductsinducecellcyclearrestandproinflammatorychangesinosteoarthriticfibroblastlikesynovialcells
AT bondevatzvetanka advancedglycationendproductsinducecellcyclearrestandproinflammatorychangesinosteoarthriticfibroblastlikesynovialcells
AT martickejulia advancedglycationendproductsinducecellcyclearrestandproinflammatorychangesinosteoarthriticfibroblastlikesynovialcells
AT hofmanngunther advancedglycationendproductsinducecellcyclearrestandproinflammatorychangesinosteoarthriticfibroblastlikesynovialcells
AT heingert advancedglycationendproductsinducecellcyclearrestandproinflammatorychangesinosteoarthriticfibroblastlikesynovialcells
AT wolfgunter advancedglycationendproductsinducecellcyclearrestandproinflammatorychangesinosteoarthriticfibroblastlikesynovialcells